NASHVILLE – Tennessee will get a $3 million share in a $105 million settlement by 45 state attorneys general with drug manufacturer GlaxoSmithKline.
State Attorney General Bob Cooper said Wednesday the settlement signals a major change in how pharmaceutical sales teams are motivated and paid, with consumers reaping the benefits ultimately.
The settlement resolves allegations that GlaxoSmithKline LLC unlawfully promoted its asthma drug Advair and antidepressant drugs Paxil and Wellbutrin.
Cooper’s office said the complaint and agreed final judgment, filed Wednesday in Davidson County Circuit Court, alleges the drug manufacturer violated state consumer protection laws by misrepresenting the uses and qualities of the three drugs.
The complaint alleges GlaxoSmithKline made false and misleading representations to promote Advair as a first-line treatment for all asthma patients, including those with minor asthma problems who only occasionally needed a rescue inhaler.
